World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00512213
Date of registration: 06/08/2007
Prospective Registration: Yes
Primary sponsor: University of Lausanne Hospitals
Public title: Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery
Scientific title: Immunonutrition Versus Standard Enteral Nutrition Before Major Surgery: A Single-center Double-blinded Controlled Randomized Superiority Trial
Date of first enrolment: September 2007
Target sample size: 154
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00512213
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Switzerland
Contacts
Name:     Nicolas Demartines, MD
Address: 
Telephone:
Email:
Affiliation:  Department of Visceral Surgery, University Hospital Center, Lausanne, Switzerland
Key inclusion & exclusion criteria

Inclusion Criteria:

- All patients admitted for elective major abdominal surgery:

- Open and laparoscopic esophageal, gastric, hepatic, pancreatic, intestinal and
colorectal surgery and with a NRS = 3.

Exclusion Criteria:

- Age < 18 years

- No informed consent

- Emergency situation

- Patients not speaking french or german.



Age minimum: 18 Years
Age maximum: 90 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Major Abdominal Surgery
Intervention(s)
Dietary Supplement: Standard enteral nutrition for 5 days preoperative
Dietary Supplement: Immunonutrition for 5 days preoperative
Primary Outcome(s)
complications after surgery [Time Frame: 30 days]
Secondary Outcome(s)
hospital stay, patient compliance, Interleukin-6 and 10 plasma level [Time Frame: 30 days]
Secondary ID(s)
P00/07 CHV
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Novartis
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history